Skip to Main Content
TRC_PLC_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • New Drugs
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Infectious Diseases
  4. HIV & AIDS
  5. Treatment

Treatment

  • Antimicrobial Stewardship (21)
  • COVID-19 (40)
  • Fever (5)
  • Fungal Infections (10)
  • H1N1 (Swine) Influenza (40)
  • HIV & AIDS (87)
    • Drug-Induced Toxicity (16)
    • Drug Interactions (15)
    • HIV Screening and Testing (12)
    • Opportunistic Infection Drug Therapies (6)
    • Prevention (32)
    • Treatment (33)
      • Antiviral Drug Therapies (31)
      • Selecting a Treatment Regimen (19)
  • Infections (60)
  • Lower Respiratory Tract Infections (127)
  • Measles (4)
  • MRSA (6)
  • Other (224)
  • Resources (574)
  • STIs (105)
  • Skin/Soft Tissue Infections (82)
  • Thrush (1)
  • Travel Medicine (89)
  • Upper Respiratory Tract Infections (177)
  • Vaccines (295)
  • West Nile Virus (10)
31 - 33 of 33 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: hypersensitivity and serious skin reactions associated with Intelence (etravirine) December 2009
Article: increased risk of heart attacks in patients taking Telzir (fosamprenavir) for HIV September 2009
Article: HIV drug called Intelence (etravirine) May 2008
  • « Prev
  • 1
  • 2
  • 3
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved